BAX vs PFE · rev $11.24B vs P/E 20, rev $15.03B
Baxter International Inc (BAX) versus Pfizer Inc (PFE) — a side-by-side from cached financials, not a winner call.
Baxter International Inc (BAX) is a medical instruments & supplies company listed on NYSE.
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla D.V.M., Ph.D..
Latest reported BAX revenue for 2025-12-31 was $11.24B. Net income was -$957.0M. BAX currently screens at market cap $10.01B.
Latest reported PFE revenue for 2026-06-28 was $15.03B. Net income was -$248.0M. Revenue was up 4.0% from 2026-03-29 to 2026-06-28. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
BAX currently screens at market cap $10.01B. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
Not investment advice. Open the BAX and PFE stock pages for the full models.
Not investment advice.